Oral Presentation: Generative AI & The Future of Drug Development: A New Era of AI Designed IPF Drug Therapy (IMAGE)

InSilico Medicine

Oral Presentation: Generative AI & The Future of Drug Development: A New Era of AI Designed IPF Drug Therapy

Caption

Presenter: Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine

Session: Respiratory Innovation Summit

Date and time: Saturday, May 17, 11:30 a.m. – 12:00 p.m. PT

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.